Aller au contenu principal
2022 conference-abstract

Role of Matrix Metalloproteinase-9 During Diabetic Ketoacidosis: Results From the Diabetic Kidney Alarm (DKA) Study

0Citations signalées — pas une note de qualité
7Institutions déclarées
3Pays d’affiliation déclarés

Résumé fourni par la source

Background: Matrix metalloproteinases (MMPs) are involved in the pathophysiology of acute and chronic kidney disease. However, their role in acute kidney injury (AKI) and proximal tubular dysfunction, a common complication of diabetic ketoacidosis (DKA), is unknown. We examined changes in MMP-9 during and 3 months after episodes of DKA in youth with known or new onset type 1 diabetes (T1D). Methods: Serum samples were collected from youth with DKA at 2 time points: 0-8 hours after starting an insulin infusion and 3 months after hospital discharge. Mixedeffects models evaluated the changes in serum MMP9 and associations with serum copeptin and uric acid and adjustments were made for estimated glomerular filtration rate (eGFR) calculated by serum creatinine and cystatin C. Data are reported as mean and standard deviation (SD) or standard error (SE), or β-estimates and SE for mixed-effects models. Results: We enrolled 40 youth (52% boys, age [mean±SD] 11±4 years, venous pH 7.2±0.1, blood glucose 451±163 mg/dL). 17% of participants (n= 7) met criteria for AKI. Concentrations of MMP-9 were significantly higher during episodes of DKA compared to 3 months follow-up (mean±SE: 1504.6±137 vs. 668.7±159 ng/mL, p=0.0003). At 0-8 hours, participants with AKI had significantly higher MMP-9 (2256.9±310.1 vs. 1344.7±143.5 ng/mL, p=0.01). Higher serum MMP9 was associated with higher serum copeptin, a surrogate marker of vasopressin, (β±SE: 12.4±3.6 per 1 pmol/L increment in copeptin) and higher uric acid (β±SE: 123.9±42.2 per 1 mg/dL increment in uric acid). Conclusions: In our study, DKA and accompanying AKI associated with elevated concentrations of serum MMP-9, a marker of oxidative stress and remodeling, potentially highlighting the underlying mechanisms of kidney injury during DKA. Funding: Other NIH Support - NIH CTSA Grant UL1 TR002535, Private Foundation Support

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Role of Matrix Metalloproteinase-9 During Diabetic Ketoacidosis: Results From the Diabetic Kidney Alarm (DKA) Study
Date Crossref
01/11/2022
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Diabetes and associated disordersNeurological and metabolic disordersDiabetes Treatment and Management

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.